Page last updated: 2024-08-23

piperacillin and Atypical Mycobacterial Infection, Disseminated

piperacillin has been researched along with Atypical Mycobacterial Infection, Disseminated in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barkan, D; Bifani, P; Meir, M	1

Other Studies

1 other study(ies) available for piperacillin and Atypical Mycobacterial Infection, Disseminated

Article	Year
The addition of avibactam renders piperacillin an effective treatment for Antimicrobial resistance and infection control, 2018, Volume: 7 Topics: Animals; Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactamases; Disease Models, Animal; Drug Combinations; Drug Synergism; Meropenem; Microbial Sensitivity Tests; Moths; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Piperacillin	2018

Article

Year

The addition of avibactam renders piperacillin an effective treatment for

Antimicrobial resistance and infection control, 2018, Volume: 7

Topics: Animals; Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactamases; Disease Models, Animal; Drug Combinations; Drug Synergism; Meropenem; Microbial Sensitivity Tests; Moths; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Piperacillin

2018